AbbVie Inc (ABBV)
Payables turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 14,866,000 | 12,856,000 | 15,129,000 | 17,193,000 | 17,097,000 | 18,881,000 | 17,418,000 | 17,348,000 | 17,414,000 | 17,564,000 | 16,932,000 | 17,285,000 | 17,446,000 | 17,810,000 | 18,470,000 | 17,658,000 | 15,387,000 | 12,709,000 | 9,579,000 | 7,687,000 |
Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $14,866,000K ÷ $—K
= —
Based on the provided data, the payable turnover ratio for AbbVie Inc is not available or provided as "—". This implies that details needed to calculate the payables turnover ratio are missing for all the specified dates.
Without the specific payables and cost of goods sold (COGS) figures, we are unable to compute the payable turnover ratio. The payables turnover ratio is a financial metric that assesses how efficiently a company is managing its payable accounts by measuring the number of times a company pays off its average accounts payable balance in a given period. A higher payables turnover ratio typically indicates that the company is paying its suppliers more frequently, which could suggest better liquidity or more favorable credit terms.
As no data is available for the payables turnover ratio, it is difficult to provide a detailed analysis of AbbVie Inc's payables management efficiency over the specified periods. It would be beneficial to obtain the necessary financial data to compute this ratio in order to assess AbbVie Inc's ability to manage its accounts payable effectively.
Peer comparison
Dec 31, 2024